Ofloxacin Tablets

MARCH 01, 2004

Teva Pharmaceuticals USA (North Wales, Pa) recently announced the introduction and availability of Ofloxacin Tablets. This product is AB-rated and is bioequivalent to Ortho-McNeil?s Floxin tablets. The product is prescribed to patients to reduce the development of drug-resistant bacteria and to maintain the effectiveness of this and other antibacterial drugs. Ofloxacin Tablets are indicated for the treatment of adults with mild-to-moderate infections (unless otherwise indicated) caused by susceptible strains of designated microorganisms. These infections include chronic bronchitis, community-acquired pneumonia, and acute pelvic inflammatory disease, among others. Ofloxacin Tablets 200, 300, and 400 mg are available in bottle sizes of 100. For more information, visit www.tevapharmusa.com.